Back to search

Article

Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in the Very Elderly with Chronic Kidney Disease: a Retrospective Cohort Study Using Real-World Data

2026-08-12

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Importance</h4> The prevalence of chronic kidney disease (CKD) is increasing, with aging being a major contributor. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are well established therapies for CKD; however, adults aged 80 years or older have been underrepresented in previous large-scale trials. Consequently, evidence regarding effects of SGLT2i therapy in this cohort remains limite...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7ffd7527-60b0-535e-87a8-8d21a44519d6
DOI
10.64898/2026.08.11.26360158
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in the Very Elderly with Chronic Kidney Disease: a Retrospective Cohort Study Using Real-World DataDOI 10.64898/2026.08.11.26360158
Estimating the population-level kidney benefits of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease in Australian primary careSemantic proximity
Chronic Kidney Disease.Semantic proximity
Cardiorenal outcomes of tirzepatide versus semaglutide in adults with type 2 diabetes and chronic kidney disease: a target trial emulation in the TriNetX Global Collaborative NetworkSemantic proximity
Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes: An Umbrella ReviewSemantic proximity
Effect of SGLT2 Inhibitors on CKD Progression and All-Cause Mortality: A Meta-Analysis of Randomized Controlled TrialsSemantic proximity
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalizationSemantic proximity
Renal outcomes of combination therapy with sodium-glucose cotransporter 2 inhibitors plus renin-angiotensin system blockers in patients with type 2 diabetes mellitus: A population-based cohort studySemantic proximity
Covid-19 in end-stage renal disease patients with renal replacement therapies: a systematic review and meta-analysisSemantic proximity
Kidney outcomes with SGLT2 inhibitors in patients with diabetes and an insulin-deficient phenotype: A real world analysis.Semantic proximity
Inference of Disease Burden for Chronic Kidney Disease Screening Intervention Based on a Micro-Simulation ModelSemantic proximity
Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patientsSemantic proximity
Predicting and Validating Risk of Pre-Pandemic and Excess Mortality in Individuals With Chronic Kidney DiseaseSemantic proximity
Select a neighboring publication to make it the new centre.